These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38031335)

  • 1. Clinical characteristics, treatment, and outcome of low-risk non-HIV-associated cryptococcal meningitis: A retrospective cohort study.
    Liu J; Dong R; Zhang H; Yao S; Liu J; Yang L; Fan L; Su X; Wang A; Su Z; Ngai IK; Dai K; Jiang Y; Peng F
    Med Mycol; 2023 Dec; 61(12):. PubMed ID: 38031335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study.
    Qu J; Jiang J; Lv X
    BMC Infect Dis; 2020 Aug; 20(1):571. PubMed ID: 32758162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a machine learning model to predict prognosis in HIV-negative cryptococcal meningitis patients: a multicenter study.
    Liu J; Lu Y; Liu J; Liang J; Zhang Q; Li H; Zhong X; Bu H; Wang Z; Fan L; Liang P; Xie J; Wang Y; Gong J; Chen H; Dai Y; Yang L; Su X; Wang A; Xiong L; Xia H; Jiang Y; Liu Z; Peng F
    Eur J Clin Microbiol Infect Dis; 2023 Oct; 42(10):1183-1194. PubMed ID: 37606868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of Early Mycological Clearance in HIV-Negative Cryptococcal Meningitis.
    Su Z; Luo C; Dai K; Yuan D; Qin BE; Gu M; Liu J; Chen Y; Peng F; Jiang Y
    Open Forum Infect Dis; 2023 Apr; 10(4):ofad158. PubMed ID: 37035489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
    Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and treatment outcomes of human immunodeficiency virus-associated cryptococcal meningitis: a 2-year retrospective analysis.
    Song W; Shen YZ; Wang ZY; Qi TK; Liu L; Zhang RF; Wang JR; Tang Y; Chen J; Sun JJ; Lu HZ
    Chin Med J (Engl); 2020 Dec; 133(23):2787-2795. PubMed ID: 33273326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection.
    Lee YC; Wang JT; Sun HY; Chen YC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):338-45. PubMed ID: 21524972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study.
    Wan Z; Tao R; Hui J; Liu X; Peng X; Guo Y; Zhu X; Huang Y; Zhu B
    J Neuroinflammation; 2023 Feb; 20(1):38. PubMed ID: 36793113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
    Jarvis JN; Bicanic T; Loyse A; Namarika D; Jackson A; Nussbaum JC; Longley N; Muzoora C; Phulusa J; Taseera K; Kanyembe C; Wilson D; Hosseinipour MC; Brouwer AE; Limmathurotsakul D; White N; van der Horst C; Wood R; Meintjes G; Bradley J; Jaffar S; Harrison T
    Clin Infect Dis; 2014 Mar; 58(5):736-45. PubMed ID: 24319084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary study on the characteristics of Th1/Th2 immune response in cerebrospinal fluid of AIDS patients with cryptococcal meningitis.
    Li A; Zhu W; Yin J; Huang X; Sun L; Hua W; Wang W; Zhang T; Dai L; Wu H
    BMC Infect Dis; 2021 May; 21(1):500. PubMed ID: 34051748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
    Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
    BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis.
    Robertson EJ; Najjuka G; Rolfes MA; Akampurira A; Jain N; Anantharanjit J; von Hohenberg M; Tassieri M; Carlsson A; Meya DB; Harrison TS; Fries BC; Boulware DR; Bicanic T
    J Infect Dis; 2014 Jan; 209(1):74-82. PubMed ID: 23945372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of Epstein-Barr virus in cerebrospinal fluid is associated with increased mortality in HIV-negative cryptococcal meningitis.
    Lu Y; Li S; Su Z; Luo C; Gu M; Yuan D; Qin BE; Dai K; Xia H; Chen Y; Peng F; Jiang Y
    Med Mycol; 2024 May; 62(5):. PubMed ID: 38710585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.
    Loyse A; Wilson D; Meintjes G; Jarvis JN; Bicanic T; Bishop L; Rebe K; Williams A; Jaffar S; Bekker LG; Wood R; Harrison TS
    Clin Infect Dis; 2012 Jan; 54(1):121-8. PubMed ID: 22052885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.
    Xu L; Liu J; Zhang Q; Li M; Liao J; Kuang W; Zhu C; Yi H; Peng F
    Neurol Res; 2018 May; 40(5):398-404. PubMed ID: 29560802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
    Maher D; Mwandumba H
    J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort.
    Vidal JE; Gerhardt J; Peixoto de Miranda EJ; Dauar RF; Oliveira Filho GS; Penalva de Oliveira AC; Boulware DR
    Diagn Microbiol Infect Dis; 2012 May; 73(1):68-73. PubMed ID: 22578940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures.
    Bicanic T; Brouwer AE; Meintjes G; Rebe K; Limmathurotsakul D; Chierakul W; Teparrakkul P; Loyse A; White NJ; Wood R; Jaffar S; Harrison T
    AIDS; 2009 Mar; 23(6):701-6. PubMed ID: 19279443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing paradigm of cryptococcal meningitis: an eight-year experience from a tertiary hospital in South India.
    Abhilash KP; Mitra S; Arul JJ; Raj PM; Balaji V; Kannangai R; Thomas SA; Abraham OC
    Indian J Med Microbiol; 2015; 33(1):25-9. PubMed ID: 25559998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.